DE60121196D1 - Verfahren zur monomerisierung von humanen serumalbumin-polymeren - Google Patents

Verfahren zur monomerisierung von humanen serumalbumin-polymeren

Info

Publication number
DE60121196D1
DE60121196D1 DE60121196T DE60121196T DE60121196D1 DE 60121196 D1 DE60121196 D1 DE 60121196D1 DE 60121196 T DE60121196 T DE 60121196T DE 60121196 T DE60121196 T DE 60121196T DE 60121196 D1 DE60121196 D1 DE 60121196D1
Authority
DE
Germany
Prior art keywords
serum albumin
human serum
multimer
uncorrected
monomers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60121196T
Other languages
English (en)
Other versions
DE60121196T2 (de
Inventor
Toshinobu Nouchi
Hiroshi Mizokami
Yoshitaka Tajima
Hiroyuki Yokote
Satoshi Adachi
Yoshinobu Miyatsu
Tetsuro Tanabe
Yoshitaka Ushio
Shinichi Shibata
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chemo Sero Therapeutic Research Institute Kaketsuken
Original Assignee
Chemo Sero Therapeutic Research Institute Kaketsuken
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2000324028A external-priority patent/JP4798831B2/ja
Priority claimed from JP2000324027A external-priority patent/JP4798830B2/ja
Application filed by Chemo Sero Therapeutic Research Institute Kaketsuken filed Critical Chemo Sero Therapeutic Research Institute Kaketsuken
Publication of DE60121196D1 publication Critical patent/DE60121196D1/de
Application granted granted Critical
Publication of DE60121196T2 publication Critical patent/DE60121196T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE60121196T 2000-10-24 2001-10-24 Verfahren zur monomerisierung von humanen serumalbumin-polymeren Expired - Lifetime DE60121196T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2000324028 2000-10-24
JP2000324027 2000-10-24
JP2000324028A JP4798831B2 (ja) 2000-10-24 2000-10-24 ヒト血清アルブミンのミスホールディングを抑制する方法
JP2000324027A JP4798830B2 (ja) 2000-10-24 2000-10-24 ヒト血清アルブミン多量体の単量体化方法
PCT/JP2001/009334 WO2002034785A1 (fr) 2000-10-24 2001-10-24 Procede de monomerisation de polymeres d"albumine serique humaine

Publications (2)

Publication Number Publication Date
DE60121196D1 true DE60121196D1 (de) 2006-08-10
DE60121196T2 DE60121196T2 (de) 2007-07-12

Family

ID=26602656

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60121196T Expired - Lifetime DE60121196T2 (de) 2000-10-24 2001-10-24 Verfahren zur monomerisierung von humanen serumalbumin-polymeren

Country Status (11)

Country Link
US (1) US20030027991A1 (de)
EP (1) EP1329460B1 (de)
KR (1) KR100827750B1 (de)
CN (2) CN1275981C (de)
AT (1) ATE331735T1 (de)
AU (1) AU783571B2 (de)
CA (1) CA2395587C (de)
DE (1) DE60121196T2 (de)
DK (1) DK1329460T3 (de)
ES (1) ES2261487T3 (de)
WO (1) WO2002034785A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2866890B1 (fr) * 2004-02-27 2008-04-04 Lab Francais Du Fractionnement Procede de purification d'albumine comprenant une etape de nanofiltration, solution et composition a usage therapeutique la contenant
JP2005245269A (ja) * 2004-03-03 2005-09-15 Nipro Corp 血清アルブミン多量体を含む遺伝子組換え型蛋白質
US20130231287A1 (en) * 2010-02-25 2013-09-05 Parimala Nacharaju Pegylated albumin polymers and uses thereof
CN102241767B (zh) * 2011-06-22 2013-07-10 河南省医药科学研究院 一种牛血清白蛋白提取方法
KR101595151B1 (ko) * 2012-01-31 2016-02-18 이화여자대학교 산학협력단 일산화질소에 의해 형성되는 알부민 다량체 및 알부민 구조변형체
JP6928084B2 (ja) 2016-10-04 2021-09-01 アルブミディクス リミティド 組換え酵母由来血清アルブミンの使用
WO2020043087A1 (en) * 2018-08-27 2020-03-05 The Hong Kong University Of Science And Technology Method of detecting human serum albumin in biological fluids
CN109111498A (zh) * 2018-09-12 2019-01-01 山东省生物制品研究所 一种减少蛋白在protein L凝胶层析中形成多聚体的方法
US20230000774A1 (en) 2019-12-04 2023-01-05 Albumedix Limited Methods and compositions produced thereby

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4169829A (en) * 1972-07-05 1979-10-02 Institut Merieux Process for the preparation of purified albumin and albumin obtained by said process
US4705848A (en) * 1986-06-02 1987-11-10 International Minerals & Chemical Corp. Isolation of bioactive, monomeric growth hormone
IL88326A (en) * 1987-11-18 1993-03-15 Gist Brocades Nv Purification of serum albumin
JPH0671434B2 (ja) * 1989-09-18 1994-09-14 株式会社ミドリ十字 ヒト血清アルブミンの製造方法
US5440018A (en) * 1992-05-20 1995-08-08 The Green Cross Corporation Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same
US5521287A (en) * 1992-05-20 1996-05-28 The Green Cross Corporation Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same
US5728553A (en) * 1992-09-23 1998-03-17 Delta Biotechnology Limited High purity albumin and method of producing
EP0658569B2 (de) * 1993-12-17 2008-11-26 Mitsubishi Pharma Corporation Verfahren zum Entfärben von menschlichen Serum-Albumin
JP4798833B2 (ja) * 2000-10-24 2011-10-19 一般財団法人化学及血清療法研究所 加熱処理工程を含むヒト血清アルブミンの製造方法
JP4798832B2 (ja) * 2000-10-24 2011-10-19 一般財団法人化学及血清療法研究所 ヒト血清アルブミン多量体の除去方法

Also Published As

Publication number Publication date
DK1329460T3 (da) 2006-07-31
EP1329460A4 (de) 2004-08-11
EP1329460A1 (de) 2003-07-23
US20030027991A1 (en) 2003-02-06
WO2002034785A1 (fr) 2002-05-02
EP1329460B1 (de) 2006-06-28
AU1093402A (en) 2002-05-06
CN1651462A (zh) 2005-08-10
CA2395587A1 (en) 2002-05-02
CN1406247A (zh) 2003-03-26
CA2395587C (en) 2012-09-18
KR20020065607A (ko) 2002-08-13
ES2261487T3 (es) 2006-11-16
CN1275981C (zh) 2006-09-20
ATE331735T1 (de) 2006-07-15
KR100827750B1 (ko) 2008-05-07
AU783571B2 (en) 2005-11-10
DE60121196T2 (de) 2007-07-12

Similar Documents

Publication Publication Date Title
WO2004043339A3 (en) Substituted cycloalkyl p1' hepatitis c virus inhibitors
WO2004032827A3 (en) Hepatitis c virus inhibitors
DE60334205D1 (en) Heterocyclische sulfonamid-hepatitis-c-virus-hemmer
DE60119968D1 (en) Hepatitis c tripeptid inhibitoren
ATE540054T1 (de) Antimikrobielle theta defensine und verfahren zu deren verwendung
HK1043543A1 (en) Modified factor VIII.
DE69739035D1 (de) Zusammensetzungen und Methoden zur Behandlung von Infektionen unter Verwendung von Indolicidinanalogen
DE60121196D1 (de) Verfahren zur monomerisierung von humanen serumalbumin-polymeren
DE60234444D1 (de) Verfahren zur herstellung von l-aminosäuren mit stämmen der familie enterobacteriaceae
ATE437647T1 (de) Transporter mit beabstandeten arginin-teilchen
EP2340830A3 (de) Hepatitis-C-Virus-Hemmer
ATE521357T1 (de) Verfahren zur behandlung von hepatitis
DE602005020165D1 (de) Verfahren zur herstellung von l-arginin, l-ornithin oder l-citrullin
NZ592705A (en) 4-amino-4-oxobutanoyl peptide cyclic analogues, inhibitors of viral replication
HK1048050A1 (en) Pharmaceutical composition for muscular anabolism
DE60114002D1 (de) VERFAHREN ZUR HERSTELLUNG KRISTALLINEr PARTIKEL ZUR INHALATION
WO2007029262A3 (en) Compositions and methods using same for the detection of viruses
EP1548107A4 (de) Chromoprotein und fluoroproteine
IL164523A0 (en) Cytokine receptor
ATE411812T1 (de) Peptide zur behandlung von infektionen mit dem herpes-virus
WO2006109174A3 (en) Hiv vaccine comprising a glycoprotein 120 signal sequence with no more than one positively charged amino acid
ATE467422T1 (de) Behandlung von aspergillus-infektionen mit thymosin alpha 1
MY142040A (en) Nitrosophenols and c-nitrosoanilines as polymerization inhibitors
WO2003064446A3 (en) Plasma protein-binding peptides from bacterial curli
DE60102272D1 (de) Verfahren zu Herstellung von substituierten Pyranen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition